The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization
NCT05011916
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Corneal Neovascularization
Interventions
DRUG:
KDR2-2 suspension eye drops
Sponsor
Zhongshan Ophthalmic Center, Sun Yat-sen University